$ARTL Up 71% Premarket 🚀 🔹 Artelo Biosciences catching major early momentum as biotech traders pile in 📈 🔹 Company is developing lipid-signaling therapeutic

$ARTL Up 71% Premarket 🚀 🔹 Artelo Biosciences catching major early momentum as biotech traders pile in 📈 🔹 Company is developing lipid-signaling therapeutics targeting pain, cancer anorexia/cachexia, glaucoma & inflammation-related conditions 🧬 🔹 Pipeline includes ART26.12 for non-opioid pain …